https://biotechmorning.com/news/parabilis-670-million-ipo-no-phase-3 Biotech Morning en 2026-06-27T14:23:04.037Z The Biotech That Raised $670 Million Before It Even Has a Phase 3 Trial https://biotechmorning.com/news/needle-free-epipen-alternative-insurance-wont-cover Biotech Morning en 2026-06-27T14:22:09.501Z A Needle-Free EpiPen Alternative Exists. Your Insurance Probably Won't Cover It. https://biotechmorning.com/news/bio-2026-china-biosecure-ai-drug-discovery Biotech Morning en 2026-06-27T14:21:11.885Z Biotech's Biggest Week Had Three Words on Everyone's Lips https://biotechmorning.com/news/ibio-ai-obesity-drug-clinical-trial Biotech Morning en 2026-06-27T14:20:16.155Z A Plant Factory Just Sent an AI-Designed Obesity Drug to the Clinic https://biotechmorning.com/news/first-muscle-gain-fshd-epicrispr-epi-321 Biotech Morning en 2026-06-27T14:19:23.888Z The First Drug to Ever Build Muscle in This Dystrophy Just Showed Up https://biotechmorning.com/news/viridian-lumvoa-fda-approval-thyroid-eye-disease Biotech Morning en 2026-06-27T14:18:33.759Z The Eye Drug That Just Beat Its Own Deadline https://biotechmorning.com/news/boehringer-immunai-t-cell-target-discovery Biotech Morning en 2026-06-27T14:17:41.284Z Boehringer's $15M Bet That the Next PD-1 Is Hiding in Your T Cells https://biotechmorning.com/news/pharma-ma-boom-2026-shopping-spree Biotech Morning en 2026-06-27T14:16:47.388Z Big Pharma Is on a $123 Billion Shopping Spree (and It's Only June) https://biotechmorning.com/news/lantheus-lnth-2501-crl-manufacturing-delay Biotech Morning en 2026-06-27T14:15:52.356Z Lantheus Had the Data. The Factory Broke the Dream. https://biotechmorning.com/news/biogen-apellis-acquisition-rd-cuts Biotech Morning en 2026-06-27T14:14:58.389Z Biogen Spent $5.6 Billion on Apellis. Then It Gutted the Lab. https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-2 Biotech Morning en 2026-06-26T14:26:31.726Z Gilead Just Dropped $5 Billion on a German Startup You've Never Heard Of https://biotechmorning.com/news/pharma-pricing-deals-trump-tariffs Biotech Morning en 2026-06-26T14:25:40.071Z Big Pharma Just Cut a Deal With the White House. Here's What They Gave Up. https://biotechmorning.com/news/daraxonrasib-doubles-survival-pancreatic-cancer Biotech Morning en 2026-06-26T14:24:42.972Z The Drug That Made an ASCO Crowd Stand and Cheer for 42 Seconds https://biotechmorning.com/news/crispr-base-editing-human-embryos-precision-ethics Biotech Morning en 2026-06-26T14:23:48.643Z Scientists Can Now Edit Human Embryos With Surgical Precision. That's the Problem. https://biotechmorning.com/news/gilead-kymera-molecular-glue-degrader-deal Biotech Morning en 2026-06-26T14:22:59.296Z Gilead Just Paid $45M for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/novartis-antares-undruggable-cancer-deal Biotech Morning en 2026-06-26T14:21:59.918Z Novartis Just Bet $1.9 Billion on a Company That Doesn't Exist Yet https://biotechmorning.com/news/moderna-in-vivo-car-t-autoimmune Biotech Morning en 2026-06-26T14:21:04.031Z Moderna Wants to Build a CAR-T Factory Inside Your Body https://biotechmorning.com/news/ucb-neurona-therapeutics-cell-therapy-epilepsy-deal Biotech Morning en 2026-06-26T14:20:09.049Z UCB Just Bet $1.15 Billion That Brain Cells Can Stop Seizures https://biotechmorning.com/news/ms-drug-does-what-no-drug-has-done-before Biotech Morning en 2026-06-26T14:19:13.108Z The MS Drug That Does What No Drug Has Done Before